![Vivek Subbiah: Super thrilled to share our paper – Variant of allele frequency: a decision-making tool in precision oncology?](https://oncodaily.com/pub/uploads/2023/07/Vivek-Subbiah-e1703016475550-1280x886.jpeg)
Photo taken from Vivek Subbiah/LinkedIn
Sep 13, 2023, 14:04
Vivek Subbiah: Super thrilled to share our paper – Variant of allele frequency: a decision-making tool in precision oncology?
Vivek Subbiah, Chief, Early-Phase Drug Development, Sarah Cannon Research Institute, made the following post on LinkedIn:
“Hot off the press: Super thrilled to share our paper – Variant of allele frequency: a decision-making tool in precision oncology? – published in a Cell Press journal Trends in Cancer !
An absolute delight to collaborate with the amazing Giuseppe Curigliano & his terrific team among many others.
PrecisionMedicine Sarah Cannon Research Institute.
A great pre-read before ESMO23 and MAP23 meetings”
For details click here
Source: Vivek Subbiah / LinkedIn